Secondary’s Announced 2.9.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here.

Company: Idera Pharmaceuticals
Symbol: IDRA
Price: Last trade $4.06
Trade Date: 2/13
Shares: 18.5 million
Underwriter(s) Goldman Sachs, J.P. Morgan
Rating=Subscription Needed

Company: The Ensign Group, Inc.
Symbol: ENSG
Price: Last trade $42.16
Trade Date: 2/12
Shares: 2.5 million
Underwriter(s) Wells Fargo Securities
Rating=Subscription Needed

Company: RedHill Biopharma Ltd.
Symbol: RDHL
Price: Last trade $14.60
Trade Date: 2/10
Shares: 690,000
Underwriter(s) Wells Fargo Securities
Co Manager(s) MLV & Co.
Rating=Subscription Needed

Company: Atara Biotherapeutics, Inc.
Symbol: ATRA
Price: Last trade $18.30
Trade Date: 2/12
Shares: 3 million
Underwriter(s) Goldman Sachs, Citigroup
Co Manager(s) Jefferies
Rating=Subscription Needed

Company: Rose Rock Midstream, L.P.
Symbol: RRMS
Price: Last trade $42.00
Trade Date: 2/10
Shares: 2 million
Underwriter(s) RBC Capital Markets, Morgan Stanley, UBS Investment Bank, Wells Fargo Securities
Rating=Subscription Needed

Company: GrubHub Inc.-Block
Symbol: GRUB
Price: Last trade $39.08
Trade Date: 2/10
Shares: 3.95 million
Underwriter(s) Morgan Stanley
Rating=Subscription Needed